Navigation Links
Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Date:11/8/2012

Results database. Recurrent prostate cancer is defined as cancer that has recurred following initial therapy, which could include surgery, radiation therapy, hormone therapy or chemotherapy.

Choline C 11 Injection has a short shelf life and must be made in a specialized facility and given to patients within minutes after production. Mayo Clinic has the integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to patients.

Choline C 11 Injection is a perfect fit for Mayo because its urologists see some of the most complex cases of recurrent prostate cancer in the country, Dr. Kwon says. He cautions that even with its advantage over conventional imaging, PET imaging with Choline C 11 injection is not a replacement for a tissue biopsy and histologic verification of recurrent prostate cancer.

"We worked very closely with the FDA to obtain approval to administer this agent," says Val Lowe, M.D., a radiologist at Mayo Clinic who worked on the new drug application. "The FDA understood our needs as an academic institution trying to bring novel technology to the clinician and they were very responsive."

The safety and effectiveness of Choline C 11 Injection were verified by a systematic review of published study reports.

Possible allergic reactions and mild injection site reactions may occur with the use of Choline C 11 Injection. However, no adverse reactions to Choline C 11 Injection have been reported other than a mild injection site reaction. Choline C 11 Injection contributes to a patient's long-term cumulative radiation exposure. Imaging errors have been reported; in particular, blood PSA levels < 2ng/ml have been associated with poor imaging performance.


'/>"/>

Contact: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
2. First targeted nanomedicine to enter human clinical studies
3. Clinical insight improves treatment with new lung cancer drug
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Mayo Clinic launches whole genome breast cancer study
6. Mayo Clinic offers newly approved treatment for acid reflux disease
7. NYU Langone experts present research, clinical advances at neurosurgeons meeting
8. Mayo Clinic breast cancer study finds new type of mutation
9. Kroenke honored for outstanding contributions in clinical research training
10. Awards celebrate clinical research that can improve health and alleviate suffering
11. Association for Psychological Science, SAGE launch Clinical Psychological Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... This summer, digital health leaders from across ... pilgrimage to San Diego, CA, the emerging digital health ... Summit produced by Living in Digital Times. ... the latest digital health innovations, exchange new information, share ... of industry’s most brilliant thinkers and doers, while elevating ...
(Date:5/20/2013)... By Dennis Thompson HealthDay Reporter , , MONDAY, ... with attention deficit-hyperactivity disorder (ADHD) are twice as likely ... the disorder when they were young, a new 30-year ... ADHD tended to have a higher body-mass index (BMI) ... of the disorder. Socioeconomics made no difference; well-off ...
(Date:5/20/2013)... subdural hematoma (PFSDH) is a serious and rare condition ... appropriate treatment, there,s an excellent chance of good long-term ... study in the May issue of Neurosurgery ... Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , The results support an ...
(Date:5/20/2013)... Philadelphia, PA (May 21, 2013) Wolters ... its Lippincott Williams & Wilkins (LWW) published journals ... annual awards competition recognizes member articles and publications ... , "It,s a tremendous honor to be recognized ... have become synonymous in the industry with quality, ...
(Date:5/20/2013)... Today, Allayo announced the debut of their ... application called Allie helps health care consumers who are ... arrange for quality health care. Ideal for busy individuals ... technology and access to personalized service from certified medical ... care needs are being met. Allie is being previewed ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Allayo Debuts Virtual Health Assistant At HealthBeat 2013 2
... application remains elusive, expert says , , WEDNESDAY, Feb. 25 ... of scientists has created two chemical compounds that appear ... a lack of oxygen. , "It is known that ... brain, which can be produced during hypoxia, it leads ...
... Chairman; Siegrist Takes on Executive PostSOUTH BEND, Ind., Feb. 25 ... transition from president and chief executive officer to chairman of ... Rick Siegrist, M.B.A., president of a Press Ganey subsidiary, PatientFlow ... Ganey Board of Directors, will take on the top executive ...
... White House to ,Protect the Safety Net, , WASHINGTON, ... two leading long-term care advocacy organizations, the American Health ... Home Care, today praised and thanked U.S. Representatives Earl ... and Ginny Brown-Waite (R-FL) for sending a new letter ...
... Laboratories(TM), a division of Ben Venue Laboratories, Inc., today ... product is AP rated and is equivalent to Imitrex(R) ... indicated for 1) the acute treatment of migraine attacks ... of cluster headache episodes. Sumatriptan Succinate Injection is not ...
... NEW YORK, February 25, 2009 The National ... awarded The City College of New York (CCNY) ... million grant to implement a unique partnership in ... award is funded by NCI,s U54 program, an ...
... COLORADO SPRINGS, Colo., Feb. 25 /PRNewswire/ -- ... the National Academy of Sciences, (NAS) report. Recognizing ... NAS report provides insight toward the path forward. ... improve and enhance the forensic sciences have been propounded, ...
Cached Medicine News:Health News:Compounds Found to Protect Rabbits From Cerebral Palsy 2Health News:Changing of the Guard at Press Ganey 2Health News:Changing of the Guard at Press Ganey 3Health News:Pomeroy, Berkley, Capito, Brown-Waite Urge Obama Administration to Protect Seniors' Care 2Health News:Pomeroy, Berkley, Capito, Brown-Waite Urge Obama Administration to Protect Seniors' Care 3Health News:Bedford Laboratories(TM) to Begin Shipping Sumatriptan Succinate Injection 2Health News:NIH awards $15.9 million to CCNY and Memorial Sloan-Kettering to create partnership 2
(Date:5/20/2013)... ROCKVILLE, Md. , May 20, 2013  Neuralstem, ... Eva Feldman , MD, PhD, principal investigator, presented ... neural stem cell (NSI-566) trial in the treatment of ... ,s disease) at the neuro diabetes special medical ... Friday. In a talk called "Recent Therapeutic Advances in ...
(Date:5/20/2013)... , May 20, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... offering a greater effect on quality of life ... Given the high level of subjectivity and variability ... interviewed thought leaders state that it is difficult ...
(Date:5/19/2013)... 20, 2013  Whole-cell pertussis vaccines were more effective ... a large recent outbreak, according to a new Kaiser ... vaccines, also called DTwP, were available from the 1940s ... ultimately led to the development of acellular pertussis vaccines, ... the United States had switched ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... , , TITUSVILLE, ... U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone ... treatment of schizophrenia in adults on Friday, July 31, ... antipsychotic approved in the U.S. for this use. Janssen((R)), ...
... NEW YORK, July 29 Grammy-Award winning artist and ... to create an exclusive (RED)ZONE seating section for his August 13th, ... Beginning July 29th, every purchase at select Gap stores in the ... shoppers to obtain one ticket in the reserved RED(ZONE) section for ...
Cached Medicine Technology:Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 2Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 3Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 4Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 5Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 6Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 7Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 9John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 2John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 3
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Maxi-Therm® hyper-hypothermia water blankets from Cincinnati Sub-Zero are designed for single-patient use. These blankets are easy to clean, stain resistant and ideal for isolation cases....
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
... Oximetry Data Management Program is a ... with the FingerPrint® Sleep Hand-Held Pulse ... PM, Inc. catalog #3389 Interface Cable, ... sleep screening, oxygen therapy validation, and/or ...
Medicine Products: